March 6th 2018: Encore: FIRVANQ 'TM' Newly Approved Vancomycin Oral Solution |eCard

SIGN-UP NOW! Click to become a The VoiceAmerica Talk Member for Free!

C. diff. Spores and More

Tuesday at 10 AM Pacific

March 6th 2018: Encore: FIRVANQ 'TM' Newly Approved Vancomycin Oral Solution

Join us with our guest, Neal I. Muni, MD, MSPH, President and CEO of CutisPharma as we discuss CutisPharma and their new FDA approved product FIRVANQ ™ Listen in as we learn more about the Company’s history, their unique product offerings that help pharmacists compound drugs, and product information for FIRVANQ ™, their recently approved vancomycin oral solution.

DOWNLOAD PDF

GET CODE

Tune in

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel

LISTEN LIVE

EPISODE ON DEMAND

VIEW HOST PAGE

Questions? Comments?
Call In Live! Call-In
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guest

Neal I. Muni, MD, MSPH

Dr. Muni joined CutisPharma as President in July 2014 and was named Chief Executive Officer in May 2015. Prior to joining CutisPharma, Dr. Muni served as the head of Corporate Strategy at Sunovion Pharmaceuticals.

Read more

Share This Episode

Share On Facebook

Share On Twitter

Share On LinkedIn

Share this E-mail

https://www.voiceamerica.com/show/2441/c-diff-spores-and-more 29/04/2024 08:00 29/04/2024 09:00 C. diff. Spores and More https://www.voiceamerica.com/show/2441/c-diff-spores-and-more Join us with our guest, Neal I. Muni, MD, MSPH, President and CEO of CutisPharma as we discuss CutisPharma and their new FDA approved product FIRVANQ ™ Listen in as we learn more about the Company’s history, their unique product offerings that help pharmacists compound drugs, and product information for FIRVANQ ™, their recently approved vancomycin oral solution. VoiceAmerica | Talk Radio | Online Talk Radio studio@voiceamerica.com false DD/MM/YYYY

Add to Calendar

Email the Host

Connect with VoiceAmerica

Download our mobile apps